The New York Entrepreneur

: Employer coverage of GLP-1 drugs for weight loss lags far behind diabetes coverage, survey finds 

Read Time:6 Second

Many employers hold off on coverage of Wegovy and similar drugs amid cost concerns and the prospect of cheaper options down the road

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Market Extra: Michael Burry of ‘Big Short’ fame is betting against high-flying semiconductor stocks
Next post How Disney can save the Marvel Cinematic Universe